Givaudan | GIVN - Cost Of Sales

Stock Price
3,092.00
Daily Change
36.00 1.18%
Monthly
-1.47%
Yearly
-23.80%
Q1 Forecast
2,956.37

Givaudan reported CHF1.05B in Cost of Sales for its fiscal semester ending in June of 2024.





Cost Of Sales Change Date
Air Liquide EUR 5.9B 415.5M Dec/2025
Akzo Nobel EUR 1.44B 84M Dec/2025
Anheuser-Busch USD 6.6B 38M Sep/2025
Arkema EUR 1.79B 12M Dec/2025
BASF EUR 10.93B 241M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Beiersdorf EUR 2.11B 130M Jun/2025
British American Tobacco GBP 3.6B 427M Dec/2025
Covestro EUR -2.68B 5.51B Sep/2025
Croda International GBP 445.5M 221.15M Dec/2024
Danone EUR 6.74B 59M Jun/2025
Diageo GBP 4.08B 166M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Givaudan CHF 1.05B 936.5M Jun/2024
Glanbia EUR 1.46B 252.3M Jan/2025
Heineken EUR 12.71B 288M Dec/2025
Henkel EUR 5.07B 260M Jun/2025
International Flavors Fragrances USD 1.83B 24M Dec/2025
Johnson Matthey GBP 5.04B 513M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
L'Oréal EUR 5.62B 71.8M Dec/2025
Merck EUR 2.1B 123M Sep/2025
Nestle CHF 23.61B 1.27B Jun/2025
Pernod Ricard EUR 2.14B 99M Dec/2025
Reckitt Benckiser GBP 2.75B 1.34B Dec/2024
SGS CHF 445M 522M Jun/2025
Sika AG CHF 2.82B 195.2M Jun/2025
Solvay EUR 860M 71M Dec/2025
Umicore EUR 8.22B 4.83B Jun/2025
Victrex GBP 80M 3.8M Dec/2025